NASDAQ : HCTI

Healthcare Triangle, Inc. — Financial statements

Healthcare · Health Information Services · United States

Last price 6.3 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 4.72M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

Healthcare Triangle, Inc. (HCTI) reported revenue of 25.67M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue25.67M13.89M11.70M33.20M45.89M35.27M
Cost of Revenue20.15M12.00M8.81M26.43M34.59M24.75M
Gross Profit5.53M1.89M2.89M6.78M11.29M10.52M
Selling, General & Admin17.59M10.42M6.15M10.40M12.17M9.20M
Research & Development474.00K536.00K429.00K799.00K8.14M5.26M
Operating Expenses20.25M11.68M7.64M12.76M23.25M15.88M
Operating Income-14.73M-9.79M-4.75M-5.99M-11.96M-5.36M
Interest Expense-305.00K-567.00K-1.21M-968.00K-212.00K-567.00K
Currency Exchange Gain (Loss)-98.00K-18.00K
Other Non Operating Income (Expenses)-1.91M857.00K7.00K12.00K
EBT Excluding Unusual Items-17.04M-9.52M-5.96M-6.94M-12.17M-5.92M
Asset Writedown41.00K41.00K-1.71M-4.37M
Other Unusual Items2.68M
Pretax Income-17.00M-9.48M-5.96M-8.65M-13.85M-5.92M
Income Tax Expense24.00K12.00K35.00K506.00K24.00K
Net Income-17.02M-9.48M-5.97M-8.69M-14.36M-5.95M
Net Income to Common-17.02M-9.48M-5.97M-8.69M-14.36M-5.95M
Free Cash Flow-15.48M-16.53M-1.08M-2.16M-5.39M-7.19M
Gross Margin21.52%13.61%24.71%20.41%24.62%29.83%
Operating Margin-57.37%-70.47%-40.62%-18.02%-26.06%-15.19%
Profit Margin-66.30%-68.22%-51.03%-26.16%-31.29%-16.87%
Free Cash Flow Margin-60.30%-118.99%-9.24%-6.51%-11.75%-20.39%
EBITDA-13.09M-9.08M-3.86M-4.42M-9.02M-3.94M
EBITDA Margin-51.00%-65.40%-33.02%-13.31%-19.65%-11.16%
D&A For EBITDA1.63M705.00K889.00K1.57M2.94M1.42M
EBIT-14.73M-9.79M-4.75M-5.99M-11.96M-5.36M
EBIT Margin-57.37%-70.47%-40.62%-18.02%-26.06%-15.19%
Advertising Expenses1.70M607.00K

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents1.91M7.62M20.00K1.23M1.34M1.77M
Cash & Short-Term Investments2.02M7.62M20.00K1.23M1.34M1.77M
Receivables7.07M2.07M1.11M3.60M5.87M9.67M
Prepaid Expenses165.00K267.00K262.00K
Other Current Assets397.00K3.19M60.00K824.00K816.00K362.00K
Total Current Assets9.65M13.15M1.45M5.65M8.02M11.80M
Property, Plant & Equipment2.38M5.00K12.00K44.00K80.00K246.00K
Goodwill2.95M2.95M1.29M
Other Intangible Assets54.83M2.81M857.00K4.08M10.46M
Other Long-Term Assets3.46M3.83M497.00K304.00K1.07M816.00K
Total Assets73.64M22.74M1.96M6.86M13.26M24.61M
Accounts Payable1.20M744.00K2.54M1.95M1.48M1.87M
Accrued Expenses1.42M946.00K1.21M
Short-Term Debt194.00K589.00K2.68M2.69M3.28M
Current Portion of Long-Term Debt9.16M10.54M2.06M1.11M
Current Portion of Leases426.00K176.00K
Current Unearned Revenue564.00K
Other Current Liabilities3.22M365.00K676.00K2.41M2.43M924.00K
Total Current Liabilities15.99M12.79M7.08M8.15M6.60M6.25M
Long-Term Debt2.66M97.00K
Other Long-Term Liabilities5.14M625.00K2.23M
Total Liabilities24.54M12.79M7.08M8.25M7.22M8.48M
Common Stock12.01M11.00K
Additional Paid-In Capital65.23M45.53M21.02M26.21M24.96M18.80M
Retained Earnings-53.49M-43.00M-33.57M-27.60M-18.92M-2.66M
Total Common Equity23.75M2.55M-12.55M-1.39M6.04M16.14M
Minority Interest-89.00K-37.00K
Shareholders' Equity49.10M9.94M-5.11M-1.39M6.04M16.14M
Total Liabilities & Equity73.64M22.74M1.96M6.86M13.26M24.61M
Total Debt13.00M10.74M2.65M3.88M2.69M3.45M
Net Cash (Debt)-10.98M-3.11M-2.63M-2.65M-1.34M-1.68M
Filing Date Shares Outstanding748.72K98.38K
Working Capital-6.34M359.00K-5.62M-2.50M1.43M5.55M
Tangible Book Value-34.02M-3.21M-12.55M-2.25M1.96M4.39M
Machinery5.29M67.00K69.00K132.00K119.00K80.00K

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income-17.02M-9.48M-5.97M-8.69M-14.36M-5.95M
Depreciation & Amortization1.58M705.00K889.00K1.57M2.94M1.42M
Other Amortization398.00K223.00K979.00K
Asset Writedown & Restructuring Costs1.71M4.37M
Loss (Gain) on Equity Investments393.00K393.00K22.00K
Stock-Based Compensation327.00K451.00K87.00K274.00K381.00K1.20M
Provision & Write-off of Bad Debts159.00K17.00K170.00K222.00K
Other Operating Activities4.13M-145.00K49.00K-12.00K-2.65M169.00K
Change in Accounts Receivable445.00K-913.00K2.31M2.27M3.58M-3.28M
Change in Accounts Payable-2.50M-1.49M593.00K484.00K-392.00K-2.48M
Change in Other Net Operating Assets-3.94M-6.29M-216.00K243.00K555.00K1.80M
Operating Cash Flow-16.03M-16.52M-1.08M-2.15M-5.35M-7.11M
Capital Expenditures547.00K-6.00K-12.00K-40.00K-79.00K
Cash Acquisitions-9.20M-4.50M
Sale (Purchase) of Intangibles-1.50M-1.50M-1.09M-3.05M
Other Investing Activities-247.00K-247.00K
Investing Cash Flow-10.39M-1.75M-12.00K-1.13M-7.63M
Short-Term Debt Issued9.41M1.56M476.00K1.07M
Total Debt Issued86.01M9.41M1.56M476.00K1.07M
Short-Term Debt Repaid-1.09M
Long-Term Debt Repaid-194.00K-181.00K
Total Debt Repaid-72.98M-1.09M-194.00K-181.00K
Net Debt Issued (Repaid)13.03M9.41M-1.09M1.56M282.00K888.00K
Issuance of Common Stock12.77M17.03M956.00K500.00K5.92M14.22M
Repurchase of Common Stock-141.00K
Other Financing Activities-737.00K-567.00K
Financing Cash Flow25.07M25.88M-133.00K2.06M6.06M15.11M
Net Cash Flow-1.32M7.61M-1.21M-107.00K-429.00K367.00K
Free Cash Flow-15.48M-16.53M-1.08M-2.16M-5.39M-7.19M
Free Cash Flow Margin-60.30%-118.99%-9.24%-6.51%-11.75%-20.39%
Levered Free Cash Flow-6.38M-13.06M1.28M196.38K-948.62K-10.85M
Unlevered Free Cash Flow-6.19M-12.93M1.05M801.38K-816.12K-10.50M
Cash Interest Paid302.00K567.00K121.00K968.00K212.00K567.00K
Cash Income Tax Paid12.00K35.00K357.00K24.00K
Change in Working Capital-5.99M-8.69M2.69M3.00M3.75M-3.95M

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization3.73M4.59M5.31M11.48M6.98M64.89M
Enterprise Value14.71M11.91M6.36M14.89M5.33M66.77M
Last Close Price4.98759.00294,729.29820,186.45536,898.725,407,828.00
Forward PE2.972.972.972.97
PS Ratio0.150.330.450.350.151.84
PB Ratio0.020.46-1.04-8.261.164.02
P/TBV Ratio3.5714.79
EV/Sales Ratio0.570.860.540.450.121.89
Debt / Equity Ratio0.271.08-0.52-2.790.450.21
Net Debt / Equity Ratio0.220.31-0.51-1.910.220.10
Net Debt / EBITDA Ratio-0.84-0.34-0.68-0.60-0.15-0.43
Net Debt / FCF Ratio-0.71-0.19-2.43-1.23-0.25-0.23
Asset Turnover0.581.122.653.302.421.98
Quick Ratio0.570.760.160.591.091.83
Current Ratio0.601.030.200.691.221.89
Return on Equity (ROE)-57.40%-392.38%-373.67%-129.50%-58.14%
Return on Assets (ROA)-20.87%-49.55%-67.34%-37.18%-39.46%-18.75%
Return on Invested Capital (ROIC)-24.68%-246.51%-196.55%-94.89%-49.84%
Return on Capital Employed (ROCE)-25.50%-98.40%92.90%462.50%-179.40%-29.20%
Earnings Yield-8,625.69%-206.33%-112.51%-75.64%-205.71%-9.17%
FCF Yield-415.20%-359.90%-20.38%-18.84%-77.27%-11.08%